IOVANCE BIOTHERAPEUTICS INC (1IOVA.MI) Stock Earnings & Estimates
Europe - Euronext Milan - BIT:1IOVA - US4622601007 - Common Stock
2.3 EUR
+0.13 (+6.04%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.189M | 164.07M 13,698.99% | 263.68M 60.71% | 420.61M 59.52% | 638.63M 51.83% | 838.47M 31.29% | 986.58M 17.66% | 1.125B 14.03% | 1.287B 14.40% | 1.456B 13.13% | ||
| EBITDA YoY % growth | -389.57M -14.72% | -439.142M -12.72% | -354.709M 19.23% | -368.069M -3.77% | -262.896M 28.57% | -157.041M 40.26% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -398.88M -16.39% | -460.559M -15.46% | -387.878M 15.78% | -402.814M -3.85% | -256.54M 36.31% | -118.018M 54.00% | 120.51M 202.11% | 168.76M 40.04% | 234.56M 38.99% | 205.35M -12.45% | 263.52M 28.33% | |
| Operating Margin | N/A | -38,734.99% | -236.41% | -152.77% | -60.99% | -18.48% | 14.37% | 17.11% | 20.85% | 15.96% | 18.10% | |
| EPS YoY % growth | -2.48 -11.71% | -1.88 24.19% | -1.30 30.85% | -1.08 17.00% | -0.59 44.99% | -0.21 65.42% | 0.17 181.14% | 0.50 203.12% | 0.76 50.51% | 0.61 -19.46% | 0.61 |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.17 35.48% | -0.16 56.18% | -0.15 54.25% | -0.14 42.84% | -0.14 16.45% |
| Revenue Q2Q % growth | 83.531M 13.35% | 84.415M 71.14% | 99.508M 65.98% | 110.64M 64.02% | 123M 47.25% |
| EBITDA Q2Q % growth | -56.513M -58.88% | -57.274M 49.33% | -47.938M 50.33% | -43.358M 31.98% | N/A |
| EBIT Q2Q % growth | -76.433M 3.46% | -66.045M 45.52% | -59.384M 47.81% | -55.542M 38.12% | -49.826M 34.81% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | -0.24 14.29% | -0.26 | 0.02 | 8.80% |
| Q2 2025 Q2Q % growth | -0.33 2.94% | -0.29 | -0.04 | -13.70% |
| Q1 2025 Q2Q % growth | -0.36 14.29% | -0.24 | -0.12 | -47.45% |
| Q4 2024 Q2Q % growth | -0.26 42.22% | -0.27 | 0.01 | 4.58% |
| Q3 2024 Q2Q % growth | -0.28 39.13% | -0.31 | 0.03 | 8.26% |
| Q2 2024 Q2Q % growth | -0.34 27.66% | -0.36 | 0.02 | 5.66% |
| Q1 2024 Q2Q % growth | -0.42 16.00% | -0.43 | 0.01 | 2.54% |
| Q4 2023 Q2Q % growth | -0.45 29.69% | -0.44 | -0.01 | -2.23% |
| Q3 2023 Q2Q % growth | -0.46 26.98% | -0.46 | 0.00 | 0.73% |
| Q2 2023 Q2Q % growth | -0.47 25.40% | -0.81 | 0.34 | 42.15% |
| Q1 2023 Q2Q % growth | -0.50 13.79% | -0.76 | 0.26 | 34.19% |
| Q4 2022 Q2Q % growth | -0.64 -1.59% | -0.65 | 0.01 | 1.52% |
| Q3 2022 Q2Q % growth | -0.63 -14.55% | -0.65 | 0.02 | 3.17% |
| Q2 2022 Q2Q % growth | -0.63 -18.87% | -0.62 | -0.01 | -1.85% |
| Q1 2022 Q2Q % growth | -0.58 -13.73% | -0.65 | 0.07 | 10.65% |
| Q4 2021 Q2Q % growth | -0.63 -34.04% | -0.57 | -0.06 | -10.72% |
| Q3 2021 Q2Q % growth | -0.55 -37.50% | -0.54 | -0.01 | -2.01% |
| Q2 2021 Q2Q % growth | -0.53 -12.77% | -0.52 | -0.01 | -1.46% |
| Q1 2021 Q2Q % growth | -0.51 7.27% | -0.50 | -0.01 | -2.79% |
| Q4 2020 Q2Q % growth | -0.47 6.00% | -0.45 | -0.02 | -4.13% |
| Q3 2020 Q2Q % growth | -0.40 | -0.47 | 0.07 | 14.90% |
| Q2 2020 Q2Q % growth | -0.47 -23.68% | -0.54 | 0.07 | 12.37% |
| Q1 2020 Q2Q % growth | -0.55 -83.33% | -0.52 | -0.03 | -5.90% |
| Q4 2019 Q2Q % growth | -0.50 | -0.42 | -0.08 | -18.12% |
| Q3 2019 Q2Q % growth | -0.40 | -0.40 | 0.00 | 0.58% |
| Q2 2019 Q2Q % growth | -0.38 | -0.30 | -0.08 | -27.98% |
| Q1 2019 Q2Q % growth | -0.30 | -0.29 | -0.01 | -3.00% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 67.455M 15.20% | 73.85M | -6.395M | -8.66% |
| Q2 2025 Q2Q % growth | 59.952M 92.73% | 71.188M | -11.236M | -15.78% |
| Q1 2025 Q2Q % growth | 49.324M 6,798.46% | 83.339M | -34.015M | -40.82% |
| Q4 2024 Q2Q % growth | 73.694M 15,189.21% | 73.841M | -147K | -0.20% |
| Q3 2024 Q2Q % growth | 58.555M 12,358.51% | 54.884M | 3.671M | 6.69% |
| Q2 2024 Q2Q % growth | 31.106M 12,860.83% | 25.08M | 6.026M | 24.03% |
| Q1 2024 Q2Q % growth | 715K | 2.117M | -1.402M | -66.23% |
| Q4 2023 Q2Q % growth | 482K | 1.419M | -937K | -66.03% |
| Q3 2023 Q2Q % growth | 470K | 4.276M | -3.806M | -89.01% |
| Q2 2023 Q2Q % growth | 240K | 3.655M | -3.415M | -93.43% |
| Q1 2023 Q2Q % growth | 204K | -204K | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 6.87% | 29.03% | 7.58% | 6.61% |
| Revenue | -1.68% | -14.76% | -2.69% | -13.88% |